Integra Lifesciences share price logo

Integra Lifesciences

NASDAQ: IART

Small Cap

$13.65

+0.04

(+0.33%)

as on

Integra Lifesciences Stock Performance

as on November 4, 2026 at 7:59 am IST

  • Day's Low

    Day's High

    $13.40
    $13.79
    downward going graph

    1.83%

    Downside

    1.03%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $8.70
    $20.49
    downward going graph

    36.26%

    Downside

    50.11%

    Upside

    downward going graph

Integra Lifesciences share price movements today

Previous Close
$13.61
Open
$13.79
Volume
893.5K
Market Cap
$991.6M
Day's Low - High
$13.40 - $13.79
52 Week Low - High
$8.70 - $20.49

Integra Lifesciences Historical Returns

1 Month Return
+ 7.33 %
3 Month Return
-23.88 %
1 Year Return
+ 18.45 %
3 Year Return
-64.88 %
5 Year Return
-81.09 %

Integra Lifesciences Stock Fundamentals & Key Indicators

Check Integra Lifesciences market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$991.6M

EPS (TTM)

0.1678

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

75.98

Industry PE ratio

-6.59

PEG Ratio

0.11

EBITDA

233.8M

Revenue (TTM)

1.7B

Profit Margin

52.46%

Return On Equity TTM

1.24%

Integra Lifesciences vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Integra Lifesciences with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Neutral$991.6M-81.09%75.9852.46%0.00%
StrongBuy$53.0B-20.46%52.8877.98%0.00%
Buy$123.5B-18.06%23.6066.69%2.96%
StrongBuy$183.8B-16.84%39.3357.12%2.37%
StrongBuy$111.9B7.05%30.8865.52%1.21%

Stock Returns calculator for Integra Lifesciences Stock including INR - Dollar returns

The Integra Lifesciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Integra Lifesciences investment value today

Current value as on today

₹1,26,855

Returns

₹26,855

(+26.85%)

Returns from Integra Lifesciences Stock

₹18,799 (+18.8%)

Dollar Impact

₹8,056 (+8.06%)

Analyst Recommendation on Integra Lifesciences Stock

Based on 5 analysts

HOLD

20.00%

Buy

40.00%

Hold

40.00%

Sell

Based on 5 analysts, 40% of analysts recommend a 'HOLD' rating for Integra Lifesciences. Average target price of $15.67

Integra Lifesciences Share Price Target

Get share price movements and forecasts by analysts on Integra Lifesciences.

What analysts predicted

12.89%UPSIDE

Target Price

$15.67

Current Price

$13.65

Analyzed by

5 Analysts

High

$22

Target

$15.67

Low

$13

Integra Lifesciences target price $15.67, a slight upside of 12.89% compared to current price of $13.65. According to 5 analysts rating.

Indian Investors' Interest in Integra Lifesciences Stock

Search interest for Integra Lifesciences Stock has increased by 279% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:279% versus previous 30 day period

Integra Lifesciences Quarterly Profit & Loss

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Total Revenue
418
380
442
382
415
402
434
391
418
411
Gross Profit
225
200
249
194
209
226
215
224
219
209
Operating Income
-3
-8
35
-15
-512
40
556
40
19
18
EBITDA
40
34
79
25
-472
54
66
62
65
38
Interest Expense
18
19
18
20
21
22
23
26
22
22
Depreciation
36
35
37
37
37
38
38
38
38
-
Income Before Tax
-15
-20
22
-30
-530
-6
4
-2
4
15
Income Tax Expense
-2
-9
3
-4
-46
-1
6
2
0
0
Net Income
-12
-10
19
-25
-484
-5
-1
-4
4
14
Net Profit Margin
54.02%
52.58%
56.27%
50.81%
50.37%
56.24%
49.52%
57.22%
52.47%
51.04%

Integra Lifesciences Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
1,188
1,472
1,517
1,371
1,542
1,557
1,541
1,610
1,635
Gross Profit
752
900
952
851
944
970
884
882
845
Operating Income
44
110
93
151
197
238
111
28
68
EBITDA
135
236
223
264
362
381
255
193
-325
Interest Expense
35
64
53
71
50
49
51
70
86
Depreciation
88
110
109
116
119
118
123
140
151
Income Before Tax
11
57
60
93
214
213
81
-18
-563
Income Tax Expense
-53
-3
9
-40
45
33
13
-11
-47
Net Income
64
60
50
133
169
180
67
-6
-516
Net Profit Margin
63.35%
61.19%
62.79%
62.03%
61.24%
62.29%
57.39%
54.77%
51.69%

Integra Lifesciences Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Net Income
-12
-10
19
-
-484
-5
-1
-4
4
14
Operating Cash Flow
40
22
50
-11
8
40
11
9
22
95
Investing Cash Flow
-322
-10
-4
-35
-21
-15
-34
-14
-43
-10
Financing Cash Flow
-93
-19
-7
35
-21
-10
24
8
-1
-46
Change in Cash
-376
0
31
-7
-21
14
2
1
-23
37

Integra Lifesciences Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
64
60
50
133
169
180
67
-6
-516
Operating Cash Flow
114
199
231
203
312
264
139
129
50
Investing Cash Flow
-1,221
-49
-162
-68
-161
-58
-94
-390
-108
Financing Cash Flow
1,168
-180
-8
121
-98
-251
-229
237
28
Change in Cash
72
-36
60
271
43
-56
-180
-30
-11

Global Institutional Holdings in Integra Lifesciences

Check out the Institutions with significant holdings in Integra Lifesciences.

Funds
Holdings
BlackRock, Inc.
13.73%
iShares
12.83%
Vanguard
8.47%
VANGUARD INDEX FUNDS
6.88%
AIM Sector Funds (Invesco Sector Funds)
4.36%

Integra Lifesciences News & Key Events

  • img

    Today's Timeline - 21 October

    Wed, 03:41 PM

    -

    Integra projects Q4 adjusted EPS of 61c-71c, revenue guidance of $413M-$433M amid Cincinnati disruption.

    Wed, 03:55 PM

    -

    Integra reaffirms FY26 adjusted EPS view at $2.30-$2.40, lowers revenue guidance to $1.634B-$1.654B.

    Thu, 05:48 AM

    -

    Integra reports Q3 revenue of $411.2 million, adjusted EPS at $0.59, amid operational disruptions and lowered forecasts.

Insights on Integra Lifesciences

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, -4.61M → 14.85M (in $), with an average increase of 136.4% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, IART stock has moved up by 13.5%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, IART has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Edwards Lifesciences Corp has given 39.0% return, outperforming this stock by 103.9%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 418.76M → 411.18M (in $), with an average decrease of 1.8% per quarter

About Integra Lifesciences

Integra LifeSciences Holdings Corporation is a medical technology company focused on the creation, production, and global distribution of advanced surgical implants and instruments. These products are utilized across various medical fields, including neurosurgery, limb reconstruction, and general surgical procedures. The company operates through two primary business segments: Codman Specialty Surgical and Tissue Technologies. The Codman Specialty Surgical division offers a comprehensive range of neurosurgical and neuro-critical care products. This includes specialized equipment for tissue ablation, dural repair solutions, cerebral spinal fluid management systems, intracranial monitoring tools, and cranial stabilization devices. Additionally, this segment provides surgical headlamps, various instrumentation, and supports these offerings with asset management software, technical assistance, and after-market services. Integra also supplies an extensive catalog of approximately 40,000 surgical instrument designs, along with a wide selection of surgical and lighting products. Its clientele spans hospitals, surgical centers, and extends to dental, podiatry, and veterinary practices. The Tissue Technologies segment specializes in innovative regenerative technology products for the treatment of both acute and chronic wounds. It further provides surgical tissue repair solutions for a multitude of applications, such as hernia repair, peripheral nerve protection and regeneration, and tendon reconstruction. This encompasses a broad array of offerings for skin and wound repair, plastic and reconstructive surgery products, bone grafting materials, and specialized nerve and tendon repair products. Integra LifeSciences distributes its diverse product portfolio internationally, reaching markets throughout the United States, Europe, Asia Pacific, and other global regions. Distribution is managed directly through its dedicated sales forces and various other channels, serving a wide array of healthcare entities including hospitals, integrated health networks, group purchasing organizations, individual clinicians, surgery centers, and other healthcare providers. Founded in 1989, Integra LifeSciences Holdings Corporation is headquartered in Princeton, New Jersey.
OrganisationIntegra Lifesciences
Headquarters1100 Campus Road, Princeton, NJ, 08540, US
IndustryMedical - Devices
CEOStuart Essig

Key Management of Integra Lifesciences

Name

Title

Mr. Michael J. McBreen

Executive VP & Chief Commercial Officer

Mr. Jeffrey A. Mosebrook

Senior VP of Finance & Principal Accounting Officer

Mr. Teshtar Elavia

Corporate VP & Chief Technology Officer

Christopher Ward

Senior Director of Investor Relations

Laurene Isip

Vice President of Global Corporate Communications & Public Relations

Ms. Lea Daniels Knight

Executive VP & CFO

Mr. Robert T. Davis Jr.

Executive Vice President of Tissue Reconstruction and Distributed Technologies

Mr. Harvinder Pal Singh

Executive VP & President of International Business

Mr. Michael D. Hutchinson

Executive VP, Chief Legal Officer & Secretary

Dr. Stuart M. Essig Ph.D.

CEO, President & Chairman

FAQs

What is Integra Lifesciences share price today?

Integra Lifesciences share price today is $13.65 as on at the close of the market. Integra Lifesciences share today touched a day high of $13.79 and a low of $13.40.

What is the 52 week high and 52 week low for Integra Lifesciences share?

Integra Lifesciences share touched a 52 week high of $20.49 on and a 52 week low of $8.70 on . Integra Lifesciences stock price today i.e. is closed at $13.65,which is 33.38% down from its 52 week high and 56.90% up from its 52 week low.

What is Integra Lifesciences's market capitalisation today?

Integra Lifesciences market capitalisation is $0.00T as on .

How to invest in Integra Lifesciences Stock (IART) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Integra Lifesciences on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Integra Lifesciences Stock (IART) from India?

Indian investors can start investing in Integra Lifesciences (IART) shares with as little as ₹94.73999786376953 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹947.40 in Integra Lifesciences stock (as per the Rupee-Dollar exchange rate as on ). Based on Integra Lifesciences share’s latest price of $13.65 as on November 4, 2026 at 2:29 am IST, you will get 0.7326 shares of Integra Lifesciences. Learn more about fractional shares .

What are the returns that Integra Lifesciences has given to Indian investors in the last 5 years?

Integra Lifesciences stock has given -81.09% share price returns and 27.47% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?